论文信息 - Safety and Survival Outcomes of 177 Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223 Ra treatment: The RALU Study - 字舞流文

Safety and Survival Outcomes of 177 Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223 Ra treatment: The RALU Study

K. Rahbar | R. Bundschuh | O. Sartor | V. Prasad | M. Eiber | M. Kurtinecz | F. Verholen | Markus Essler | P. Rassek | E. Hasa | K. Pabst | Christian la Foug | Helmut Dittmann | W. Fendler | Anja Schmall